| |
| |
|
| Insider
Information: |
Ackermann Michael |
| Relationship: |
Director |
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,360,435 |
|
|
Indirect Shares
|
240,567 |
|
|
| Direct
Value |
$1,699,650 |
|
|
|
Indirect Value
|
$1,570,133 |
|
|
| Total
Shares |
1,601,002 |
|
|
| Total
Value |
$3,269,783 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Oyster Point Pharma, Inc. |
OYST |
Director |
2020-06-08 |
152,162 |
2020-06-08 |
140,567 |
Premium* |
|
|
Tarsus Pharmaceuticals, Inc. |
TARS |
Director |
2022-06-15 |
1,208,273 |
2022-06-15 |
100,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TARS |
Tarsus Pharmaceuticals, I... |
Director |
– • – |
2022-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,257 |
1,208,273 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
Director |
– • – |
2022-05-05 |
4 |
B |
$13.50 |
$1,350,000 |
I/I |
100,000 |
100,000 |
2.1 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
Director |
– • – |
2021-12-01 |
4 |
AS |
$23.85 |
$143,934 |
D/D |
(5,833) |
1,204,016 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
Director |
– • – |
2021-11-01 |
4 |
AS |
$27.76 |
$162,289 |
D/D |
(5,833) |
1,209,849 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
Director |
– • – |
2021-10-12 |
4 |
AS |
$25.56 |
$148,000 |
D/D |
(5,633) |
1,215,682 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
Director |
– • – |
2021-10-08 |
4 |
AS |
$25.03 |
$5,006 |
D/D |
(200) |
1,221,315 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
Director |
– • – |
2021-09-01 |
4 |
AS |
$25.24 |
$147,237 |
D/D |
(5,833) |
1,221,515 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
Director |
– • – |
2021-08-11 |
4 |
AS |
$25.15 |
$15,619 |
D/D |
(621) |
1,227,348 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
Director |
– • – |
2021-08-09 |
4 |
AS |
$25.00 |
$17,500 |
D/D |
(700) |
1,227,969 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
Director |
– • – |
2021-08-06 |
4 |
AS |
$25.00 |
$78,225 |
D/D |
(3,129) |
1,228,669 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
Director |
– • – |
2021-08-05 |
4 |
AS |
$25.00 |
$34,577 |
D/D |
(1,383) |
1,231,798 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
Director |
– • – |
2021-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
4,257 |
1,233,181 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
Director |
– • • |
2020-10-20 |
4 |
A |
$0.00 |
$0 |
D/D |
63,185 |
1,228,924 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
Director |
– • • |
2020-10-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,165,739 |
|
- |
|
| OYST |
Oyster Point Pharma, Inc. |
Director |
– • – |
2020-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
14,805 |
152,162 |
0 |
- |
|
| OYST |
Oyster Point Pharma, Inc. |
Director |
– • – |
2019-11-04 |
4 |
A |
$0.00 |
$0 |
I/I |
140,567 |
140,567 |
0 |
- |
|
| OYST |
Oyster Point Pharma, Inc. |
Director |
– • – |
2019-10-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
137,357 |
|
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
